InsiderTrades.com logo

ESPR Insider Trading

Insider Ownership Percentage: 1.70%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $143,068.06

Esperion Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Esperion Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Esperion Therapeutics Share Price & Price History

Current Price: $2.62
Price Change: ▲ Price Increase of +0.07 (2.75%)
As of 03/23/2026 05:00 PM ET

This chart shows the closing price history over time for ESPR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Esperion Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/17/2026Benjamin HalladayCFOSell6,424$2.71$17,409.04713,602View SEC Filing Icon  
3/17/2026Benjamin LookerInsiderSell5,708$2.70$15,411.60679,348View SEC Filing Icon  
1/20/2026Benjamin LookerGeneral CounselSell1,689$2.88$4,864.32384,216View SEC Filing Icon  
12/17/2025Benjamin HalladayCFOSell7,337$3.67$26,926.79467,525View SEC Filing Icon  
12/17/2025Benjamin LookerGeneral CounselSell6,517$3.67$23,917.39385,905View SEC Filing Icon  
9/17/2025Benjamin HalladayCFOSell7,046$2.81$19,799.26474,862View SEC Filing Icon  
9/17/2025Benjamin LookerGeneral CounselSell6,267$2.80$17,547.60393,670View SEC Filing Icon  
7/17/2025Benjamin HalladayCFOSell11$1.11$12.21474,462View SEC Filing Icon  
7/17/2025Benjamin LookerGeneral CounselSell1,304$1.13$1,473.52399,937View SEC Filing Icon  
6/17/2025Benjamin HalladayCFOSell7,229$1.15$8,313.35474,473View SEC Filing Icon  
6/17/2025Benjamin LookerGeneral CounselSell6,422$1.15$7,385.30401,241View SEC Filing Icon  
4/17/2025Benjamin HalladayCFOSell8$0.96$7.68481,702View SEC Filing Icon  
3/18/2025Benjamin HalladayCFOSell3,535$1.48$5,231.80481,710View SEC Filing Icon  
2/19/2025Benjamin HalladayCFOSell11$1.86$20.46240,671View SEC Filing Icon  
1/17/2025Benjamin HalladayCFOSell9$2.27$20.43240,682View SEC Filing Icon  
10/17/2024Eric WarrenInsiderSell107$2.12$226.84162,552View SEC Filing Icon  
7/17/2024Eric WarrenInsiderSell108$2.59$279.72165,478View SEC Filing Icon  
9/20/2023Eric WarrenInsiderSell742$1.25$927.5068,318View SEC Filing Icon  
8/18/2023Eric WarrenInsiderSell243$1.41$342.6369,060View SEC Filing Icon  
7/19/2023Eric WarrenInsiderSell106$1.58$167.4869,303View SEC Filing Icon  
6/21/2023Eric WarrenInsiderSell603$1.48$892.4469,409View SEC Filing Icon  
5/17/2023Eric WarrenInsiderSell219$1.62$354.7870,012View SEC Filing Icon  
5/10/2023J Martin CarrollDirectorBuy8,409$1.49$12,529.4113,409View SEC Filing Icon  
5/9/2023Sheldon L KoenigCEOBuy20,000$1.26$25,200.00312,816View SEC Filing Icon  
4/19/2023Benjamin LookerGeneral CounselSell1,290$1.27$1,638.3083,663View SEC Filing Icon  
4/19/2023Eric WarrenInsiderSell115$1.28$147.2070,231View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Esperion Therapeutics (NASDAQ:ESPR)

47.39% of Esperion Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ESPR by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Esperion Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/20/2026Hsbc Holdings PLC18,510$70K0.0%N/A0.007%Search for SEC Filing on Google Icon
3/3/2026Caitong International Asset Management Co. Ltd36,744$0.14M0.0%+17.6%0.015%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.765,118$2.83M0.0%+23.5%0.320%Search for SEC Filing on Google Icon
2/18/2026Mackenzie Financial Corp336,992$1.24M0.0%+23.5%0.141%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd161,974$0.60M0.0%N/A0.068%Search for SEC Filing on Google Icon
2/18/2026nVerses Capital LLC67,450$0.25M0.6%N/A0.028%Search for SEC Filing on Google Icon
2/18/2026Virtus Investment Advisers LLC177,508$0.66M0.2%N/A0.074%Search for SEC Filing on Google Icon
2/18/2026Wellington Management Group LLP641,178$2.37M0.0%-5.9%0.268%Search for SEC Filing on Google Icon
2/18/2026Quadrature Capital Ltd259,563$0.96M0.0%N/A0.109%Search for SEC Filing on Google Icon
2/18/2026Orbimed Advisors LLC5,965,498$22.07M0.5%N/A2.495%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC3,932,274$14.55M0.0%+303.4%1.645%Search for SEC Filing on Google Icon
2/18/2026Eversept Partners LP3,851,133$14.25M0.7%N/A1.611%Search for SEC Filing on Google Icon
2/18/2026ACT Capital Management LLC47,500$0.18M0.1%N/A0.020%Search for SEC Filing on Google Icon
2/17/2026Schonfeld Strategic Advisors LLC75,238$0.28M0.0%N/A0.031%Search for SEC Filing on Google Icon
2/17/2026Burkehill Global Management LP400,000$1.48M0.1%N/A0.167%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC290,514$1.08M0.0%+2.0%0.122%Search for SEC Filing on Google Icon
2/17/2026Abel Hall LLC28,943$0.11M0.0%+138.4%0.012%Search for SEC Filing on Google Icon
2/17/2026Cetera Investment Advisers31,803$0.12M0.0%-47.7%0.013%Search for SEC Filing on Google Icon
2/17/2026Lazard Asset Management LLC33,741$0.13M0.0%N/A0.014%Search for SEC Filing on Google Icon
2/17/2026PenderFund Capital Management Ltd.4,391,926$16.25M2.6%-54.6%1.837%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD188,639$0.70M0.0%+23.4%0.079%Search for SEC Filing on Google Icon
2/17/2026Osaic Holdings Inc.86,443$0.32M0.0%+6.2%0.036%Search for SEC Filing on Google Icon
2/17/2026Russell Investments Group Ltd.21,573$80K0.0%-98.7%0.009%Search for SEC Filing on Google Icon
2/17/2026Captrust Financial Advisors10,858$40K0.0%N/A0.005%Search for SEC Filing on Google Icon
2/17/2026ExodusPoint Capital Management LP34,815$0.13M0.0%N/A0.015%Search for SEC Filing on Google Icon
2/17/2026Royal Bank of Canada8,576$32K0.0%-99.1%0.004%Search for SEC Filing on Google Icon
2/17/2026Graham Capital Management L.P.161,557$0.60M0.0%+968.9%0.068%Search for SEC Filing on Google Icon
2/16/2026Mariner LLC278,661$1.03M0.0%-7.9%0.117%Search for SEC Filing on Google Icon
2/16/2026Barclays PLC443,339$1.64M0.0%+32.1%0.185%Search for SEC Filing on Google Icon
2/13/2026Kestra Advisory Services LLC9,570$35K0.0%N/A0.004%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP5,471,611$20.25M0.0%+117.0%2.289%Search for SEC Filing on Google Icon
2/13/2026Hudson Bay Capital Management LP18,230$67K0.0%N/A0.008%Search for SEC Filing on Google Icon
2/13/2026Rafferty Asset Management LLC61,045$0.23M0.0%+116.1%0.026%Search for SEC Filing on Google Icon
2/13/2026Headlands Technologies LLC221,088$0.82M0.1%+129.7%0.092%Search for SEC Filing on Google Icon
2/13/2026Velan Capital Investment Management LP1,210,000$4.48M2.6%N/A0.506%Search for SEC Filing on Google Icon
2/13/2026Charles Schwab Investment Management Inc.715,326$2.65M0.0%+22.0%0.299%Search for SEC Filing on Google Icon
2/13/2026State Street Corp5,930,296$21.94M0.0%+32.4%2.481%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN263,188$0.97M0.0%+80.4%0.110%Search for SEC Filing on Google Icon
2/13/2026Summit Financial LLC107,263$0.40M0.0%+8.7%0.045%Search for SEC Filing on Google Icon
2/12/2026Wasatch Advisors LP9,445,759$34.95M0.2%+33.8%3.951%Search for SEC Filing on Google Icon
2/12/2026HRT Financial LP239,360$0.89M0.0%+51.6%0.100%Search for SEC Filing on Google Icon
2/12/2026MetLife Investment Management LLC129,735$0.48M0.0%+21.8%0.054%Search for SEC Filing on Google Icon
2/12/2026Cibc World Markets Corp15,477$57K0.0%N/A0.006%Search for SEC Filing on Google Icon
2/12/2026Commonwealth Equity Services LLC23,009$85K0.0%+31.4%0.010%Search for SEC Filing on Google Icon
2/12/2026Tocqueville Asset Management L.P.107,000$0.40M0.0%+17.6%0.045%Search for SEC Filing on Google Icon
2/12/2026Renaissance Technologies LLC2,194,600$8.12M0.0%+183.6%0.918%Search for SEC Filing on Google Icon
2/12/2026EntryPoint Capital LLC23,500$87K0.0%N/A0.010%Search for SEC Filing on Google Icon
2/12/2026Integrated Quantitative Investments LLC72,249$0.27M0.1%N/A0.030%Search for SEC Filing on Google Icon
2/12/2026New York State Common Retirement Fund63,900$0.24M0.0%+103.5%0.027%Search for SEC Filing on Google Icon
2/12/2026Bank of Montreal Can51,923$0.19M0.0%+24.0%0.022%Search for SEC Filing on Google Icon
2/12/2026Polen Capital Management LLC116,292$0.43M0.0%N/A0.049%Search for SEC Filing on Google Icon
2/12/2026Nuveen LLC3,612,113$13.37M0.0%-2.7%1.511%Search for SEC Filing on Google Icon
2/11/2026Deutsche Bank AG1,072,203$3.97M0.0%+805.4%0.449%Search for SEC Filing on Google Icon
2/11/2026JPMorgan Chase & Co.965,059$3.57M0.0%+2.1%0.404%Search for SEC Filing on Google Icon
2/11/2026Los Angeles Capital Management LLC67,751$0.25M0.0%+40.6%0.028%Search for SEC Filing on Google Icon
2/11/2026Two Seas Capital LP11,902,521$44.04M0.9%+22.1%4.979%Search for SEC Filing on Google Icon
2/11/2026WINTON GROUP Ltd58,345$0.22M0.0%-17.7%0.024%Search for SEC Filing on Google Icon
2/11/2026Parallel Advisors LLC106,684$0.40M0.0%-9.1%0.045%Search for SEC Filing on Google Icon
2/11/2026State of Wyoming63,352$0.23M0.0%N/A0.027%Search for SEC Filing on Google Icon
2/10/2026Goldman Sachs Group Inc.2,848,216$10.54M0.0%+66.7%1.191%Search for SEC Filing on Google Icon
2/10/2026Intech Investment Management LLC104,938$0.39M0.0%+5.5%0.044%Search for SEC Filing on Google Icon
2/9/2026Eaton Financial Holdings Company LLC46,595$0.17M0.0%+9.4%0.019%Search for SEC Filing on Google Icon
2/9/2026PSI Advisors LLC22,344$83K0.0%+65.5%0.009%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC5,737,651$21.23M0.0%+20.8%2.400%Search for SEC Filing on Google Icon
2/9/2026Royce & Associates LP3,601,523$13.33M0.1%+57.0%1.507%Search for SEC Filing on Google Icon
2/9/2026Cary Street Partners Financial LLC10,175$38K0.0%N/A0.004%Search for SEC Filing on Google Icon
2/6/2026Larson Financial Group LLC10,500$39K0.0%N/A0.004%Search for SEC Filing on Google Icon
2/6/2026ProShare Advisors LLC53,315$0.20M0.0%+29.0%0.022%Search for SEC Filing on Google Icon
2/6/2026Summit Wealth Group LLC340,606$1.26M0.3%+5.5%0.142%Search for SEC Filing on Google Icon
2/6/2026HighTower Advisors LLC113,899$0.42M0.0%-5.1%0.048%Search for SEC Filing on Google Icon
2/4/2026Versor Investments LP51,800$0.19M0.0%N/A0.022%Search for SEC Filing on Google Icon
2/2/2026AIGH Capital Management LLC4,000,000$14.80M3.6%+33.3%1.673%Search for SEC Filing on Google Icon
1/30/2026North Star Investment Management Corp.45,000$0.17M0.0%+28.6%0.019%Search for SEC Filing on Google Icon
1/30/2026R Squared Ltd15,173$56K0.0%+23.5%0.006%Search for SEC Filing on Google Icon
1/29/2026Vanguard Group Inc.14,945,454$55.30M0.0%+23.6%6.252%Search for SEC Filing on Google Icon
1/29/2026China Universal Asset Management Co. Ltd.38,955$0.14M0.0%+10.2%0.016%Search for SEC Filing on Google Icon
1/27/2026Round Rock Advisors LLC101,553$0.38M0.1%N/A0.042%Search for SEC Filing on Google Icon
1/26/2026Mirae Asset Global Investments Co. Ltd.11,617$43K0.0%+49.0%0.005%Search for SEC Filing on Google Icon
1/21/2026KFG Wealth Management LLC10,000$37K0.0%N/A0.004%Search for SEC Filing on Google Icon
1/21/2026Capital Advisors Wealth Management LLC67,555$0.25M0.0%+58.7%0.028%Search for SEC Filing on Google Icon
1/20/2026Savvy Advisors Inc.60,000$0.22M0.0%N/A0.025%Search for SEC Filing on Google Icon
1/12/2026Traynor Capital Management Inc.14,386$53K0.0%N/A0.006%Search for SEC Filing on Google Icon
1/9/2026SG Americas Securities LLC50,997$0.19M0.0%-50.8%0.021%Search for SEC Filing on Google Icon
1/8/2026Wealth Enhancement Advisory Services LLC28,338$0.11M0.0%+18.5%0.012%Search for SEC Filing on Google Icon
1/1/2026JPMorgan Chase & Co.945,491$2.51M0.0%+68.4%0.396%Search for SEC Filing on Google Icon
11/21/2025CIBC Bancorp USA Inc.21,286$56K0.0%N/A0.009%Search for SEC Filing on Google Icon
11/19/2025Caitong International Asset Management Co. Ltd31,252$83K0.1%+40,487.0%0.013%Search for SEC Filing on Google Icon
11/17/2025Eaton Financial Holdings Company LLC42,595$0.11M0.0%N/A0.018%Search for SEC Filing on Google Icon
11/17/2025Woodline Partners LP382,087$1.01M0.0%-74.6%0.160%Search for SEC Filing on Google Icon
11/17/2025Two Seas Capital LP9,749,724$25.84M0.4%-2.1%4.078%Search for SEC Filing on Google Icon
11/17/2025Voleon Capital Management LP207,880$0.55M0.0%N/A0.087%Search for SEC Filing on Google Icon
11/17/2025Wasatch Advisors LP7,061,857$18.71M0.1%-31.7%2.954%Search for SEC Filing on Google Icon
11/17/2025Prelude Capital Management LLC65,327$0.17M0.0%-75.4%0.027%Search for SEC Filing on Google Icon
11/17/2025Mariner LLC302,514$0.80M0.0%N/A0.127%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC974,856$2.58M0.0%+115.4%0.408%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.93,773$0.25M0.0%-12.8%0.039%Search for SEC Filing on Google Icon
11/17/2025Brevan Howard Capital Management LP263,276$0.70M0.0%+234.5%0.110%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE304,572$0.81M0.0%-63.6%0.127%Search for SEC Filing on Google Icon
11/17/2025Alliancebernstein L.P.211,760$0.56M0.0%-24.3%0.089%Search for SEC Filing on Google Icon
11/14/2025Raymond James Financial Inc.60,093$0.16M0.0%+46.4%0.025%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Esperion Therapeutics logo
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C). Its marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease who require additional lowering of LDL-C. The company's products also include NILEMDO, an ATP Citrate Lyase (ACL) inhibitor that lowers LDL-C and cardiovascular risk by reducing cholesterol biosynthesis and up-regulating the LDL receptors; and NUSTENDI, a bempedoic acid and ezetimibe tablet to treat elevated LDL-C. The company has license and collaboration agreements with Daiichi Sankyo Co. Ltd to; Otsuka Pharmaceutical Co., Ltd; and Daiichi Sankyo Europe GmbH. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.
Read More on Esperion Therapeutics

Today's Range

Now: $2.62
Low: $2.47
High: $2.68

50 Day Range

MA: $3.15
Low: $2.44
High: $3.57

52 Week Range

Now: $2.62
Low: $0.69
High: $4.18

Volume

4,628,417 shs

Average Volume

4,974,792 shs

Market Capitalization

$672.84 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.11

Who are the company insiders with the largest holdings of Esperion Therapeutics?

Esperion Therapeutics' top insider investors include:
  1. Benjamin Halladay (CFO)
  2. Benjamin Looker (Insider)
  3. Benjamin Looker (General Counsel)
  4. Eric Warren (Insider)
Learn More about top insider investors at Esperion Therapeutics.

Who are the major institutional investors of Esperion Therapeutics?

Esperion Therapeutics' top institutional shareholders include:
  1. Vanguard Group Inc. — 6.25%
  2. Two Seas Capital LP — 4.98%
  3. Wasatch Advisors LP — 3.95%
  4. Orbimed Advisors LLC — 2.50%
  5. State Street Corp — 2.48%
  6. Geode Capital Management LLC — 2.40%
Learn More about top institutional investors of Esperion Therapeutics stock.

Which major investors are selling Esperion Therapeutics stock?

During the last quarter, ESPR stock was sold by these institutional investors:
  1. PenderFund Capital Management Ltd.
  2. Russell Investments Group Ltd.
  3. Royal Bank of Canada
  4. Group One Trading LLC
  5. Simplex Trading LLC
  6. Nuveen LLC
  7. SG Americas Securities LLC
  8. Wellington Management Group LLP
Within the last year, company insiders that have sold Esperion Therapeutics company stock include:
  1. Benjamin Halladay (CFO)
  2. Benjamin Looker (Insider)
  3. Benjamin Looker (General Counsel)
Learn More investors selling Esperion Therapeutics stock.

Which major investors are buying Esperion Therapeutics stock?

During the last quarter, ESPR stock was acquired by institutional investors including:
  1. Orbimed Advisors LLC
  2. Eversept Partners LP
  3. Millennium Management LLC
  4. Marshall Wace LLP
  5. Vanguard Group Inc.
  6. Wasatch Advisors LP
  7. Two Seas Capital LP
  8. State Street Corp